A61P 5/16
For decreasing, blocking or antagonising the activity of the thyroid hormones
Official title: for decreasing, blocking or antagonising the activity of the thyroid hormones
A61P5/16 (For decreasing, blocking or antagonising the activity of the thyroid hormones) appears on 559 US grants and 826 published applications in this corpus.
Search patents in A61P- Granted patents
- 559
- Published applications
- 826
- Assignees
- 314
- Inventors
- 1,649
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 3 |
| 2002 | 10 | 15 |
| 2003 | 14 | 36 |
| 2004 | 13 | 35 |
| 2005 | 10 | 35 |
| 2006 | 11 | 28 |
| 2007 | 13 | 24 |
| 2008 | 18 | 42 |
| 2009 | 20 | 51 |
| 2010 | 34 | 50 |
| 2011 | 30 | 48 |
| 2012 | 44 | 87 |
| 2013 | 61 | 56 |
| 2014 | 54 | 62 |
| 2015 | 44 | 44 |
| 2016 | 37 | 34 |
| 2017 | 25 | 37 |
| 2018 | 23 | 25 |
| 2019 | 18 | 22 |
| 2020 | 24 | 24 |
| 2021 | 12 | 14 |
| 2022 | 5 | 15 |
| 2023 | 8 | 14 |
| 2024 | 9 | 9 |
| 2025 | 6 | 13 |
| 2026 | 5 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pyridazinone compounds25 Aug 2026US 12,715,858 B2Inventisbio Co., Ltd.
- Anti-insulin-like growth factor 1 receptor (IGF-1R) antibodies and method of use thereof to treat thyroid-associated opthamology9 Jun 2026US 12,649,795 B2Suzhou Pro-heal Pharmaceuticals technology Co., Ltd.
- Humanized anti-il-4Rα single domain antibody and application thereof26 May 2026US 12,637,512 B2Regenecore Biotech Co., Ltd
- Chemical compound as thyroid hormone beta receptor agonist and use thereof5 May 2026US 12,617,769 B2Sunshine Lake Pharma Co., Ltd.
- Aqueous pharmaceutical composition of an anti-IL17A antibody and use thereof27 Jan 2026US 12,534,525 B2
- Anti-igf-1r antibodies and uses thereof27 Aug 2026US 2026/0250400 A1Suzhou Pro-heal Pharmaceuticals technology Co., Ltd.
- Process for synthesis of res metirom and its intermediates thereof21 May 2026US 2026/0138971 A1Royal Pharma
- Polycyclic thyroid hormone b receptor agonist and use thereof19 Feb 2026US 2026/0048060 A1Cascade Pharmaceuticals, Inc.
- Methods for treating allan-herndon-dudley syndrome4 Dec 2025US 2025/0367148 A1Dexcel Pharma Technologies Ltd.
- 3,4-dihydroquinolin-2(1h)-one compound27 Nov 2025US 2025/0361210 A1Kissei Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents342US 6,309,663 B1Lipocine Inc. · 2001
- Anti-CD3 antibodies and methods of use thereof196US 7,728,114 B2NovImmune S.A. · 2010